We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Silk Fibroin-Based Therapeutics for Impaired Wound Healing.
- Authors
Lehmann, Tanner; Vaughn, Alyssa E.; Seal, Sudipta; Liechty, Kenneth W.; Zgheib, Carlos
- Abstract
Impaired wound healing can lead to local hypoxia or tissue necrosis and ultimately result in amputation or even death. Various factors can influence the wound healing environment, including bacterial or fungal infections, different disease states, desiccation, edema, and even systemic viral infections such as COVID-19. Silk fibroin, the fibrous structural-protein component in silk, has emerged as a promising treatment for these impaired processes by promoting functional tissue regeneration. Silk fibroin's dynamic properties allow for customizable nanoarchitectures, which can be tailored for effectively treating several wound healing impairments. Different forms of silk fibroin include nanoparticles, biosensors, tissue scaffolds, wound dressings, and novel drug-delivery systems. Silk fibroin can be combined with other biomaterials, such as chitosan or microRNA-bound cerium oxide nanoparticles (CNP), to have a synergistic effect on improving impaired wound healing. This review focuses on the different applications of silk-fibroin-based nanotechnology in improving the wound healing process; here we discuss silk fibroin as a tissue scaffold, topical solution, biosensor, and nanoparticle.
- Subjects
SILK fibroin; TISSUE scaffolds; MYCOSES; SILK; WOUND healing; BACTERIAL diseases; DRUG delivery systems
- Publication
Pharmaceutics, 2022, Vol 14, Issue 3, p651
- ISSN
1999-4923
- Publication type
Article
- DOI
10.3390/pharmaceutics14030651